Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external video platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name Youtube
Purpose External media

Experimental radiobiology of ion beams

Back

In treatment planning, the increased effectiveness of ion beams is considered by the relative biological effectiveness (RBE). As the RBE depends on ion species, linear energy transfer (LET), dose as well as on various biological factors, it is calculated by biomathematical models. These models were initially developed based on in vitro data but need to be further validated in vivo. Our group performs systematic dose response studies at the Heidelberg Ion Beam Therapy Center (HIT) to determine preclinical RBE-values in normal tissues and tumors as a function of the most important physical and biological parameters. For preclinical normal tissue, the RBE is determined at different positions within a 6 cm spread-out Bragg peak (SOBP) using different dose levels and ion species. The results are used to benchmark predictions of clinically applied RBE-models. For preclinical tumors, the impact of hypoxia, tumor differentiation and tumor growth on local tumor control is determined. These experiments are supported by imaging studies to identify predictive parameters for normal tissue and tumor response. Further investigations on the histological and molecular level are performed to identify the mechanisms.

Selected publications

 

Reviews

  • Karger C.P., Glowa C., Peschke P. Kraft-Weyrather W.: The RBE in ion beam radiotherapy: From experimental studies to clinical application. Zeitschrift für Medizinische Physik 31, 105-121, 2021 https://doi.org/10.1016/j.zemedi.2020.12.001
  • Verhaegen F., Dubois L., Gianolini S., Hill M.A., Karger C.P., Lauber K., Prise K.M., Sarrut D., Thorwarth D., Vanhove C., Vojnovic B., Weersink R., Wilkens J.J., Georg D.: ESTRO ACROP: Technology for precision small animal radiotherapy research: Optimal use and challenges. Radiotherapy and Oncology 126, 471–478, 2018 https://www.sciencedirect.com/science/article/pii/S0167814017327330?via%3Dihub

 

to top
powered by webEdition CMS